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1. In~oductio~ 
Vasopressin and glucagon exert a number of rapid 
effects on the liver, which include stimulation of 
~ycogenolysis f 1,2], activation of phospho~lase 
[3,4] and enhancement of gluconeogenesis [5,6]. It 
seems likely that these hormones exert their effects 
in different ways, since unlike glucagon, vasopressin 
does not increase the hepatic cyclic AMP concentra- 
tion [7] and increases glycolytic flux [8]. Glucagon 
(or cyclic AMP) stimulates ketogenesis [9]. This has 
been suggested to result from a decrease in the con- 
centmtion of m~onyl-CoA which inhibits carnitine 
acyltransferase I (EC 2.3.1.2 1), an enzyme required 
for the entry of long-chain acyl-CoA into the mite- 
chondrion for oxidation [lO,l l]. The decrease in 
malonyl-CoA is associated with ambition of lipo- 
genesis [IO]. Vasopressin was demonstrated to inhibit 
ketogenesis inhepatocytes from fed rats when oleate 
is the added substrate [8]. However, vasopressin does 
not stimulate lipogenesis [8,12]. This suggests hat 
the antiketogenic action of vasopressin does not result 
from an increase in the malonyl-CoA concentration. 
The ~tiketo~enic effect might in part result from the 
increased conversion of oleoyl-CoA into esterified 
products [8] and consequently ess oxidation of 
oleoyl-CoA to acetyl-CoA. A possible ffect of vaso- 
pressin on the complete oxidation of oleate was not 
investigated in [8]. This communication i dicates that 
there is an intramitochondrial site of action of vaso- 
pressin, namely increased oxidation of [ 1 -r4C] oleate 
to CO,. This action of vasopresain is dependent on 
Ca2+ and may contribute to the antiketogenic action 
of the hormone. 
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2. M&erials and methods 
2.1. Reagents 
All enzymes and coenzymes were obtained from 
Boehringer Corp., London W5. lA~in~e]-vasopressin 
(grade VIII) and glucagon were obtained from Sigma 
(London) Chemical Co., Poole. [ 1 -14C] Oleate and 
3HZ0 were purchased from The Radiochemical 
Centre, Amersham. 
2.2. Preparation of hepatocytes 
Female Wistar ats (180-250 g) were fed ad libitum 
on standard laboratory diet. They were anaes~etized 
with Nembutal(60 mg/kg body wt; solution in 0.9% 
NaCl). Isolated hepatocytes were prepared essentially 
as in [ 131 and modified as in [ 141. Preparation of 
hepatocytes was commenced between 9:30 and 
lo:30 h. 
2.3. Experimental procedure 
The ~cubation procedure and rne~u~rnen~ of
esterification of [l-‘4C]oleate and its conversion to 
r4C!02 were as in [ 151. Acetoacetate and D3-hydroxy- 
butyrate were determined in neutralized HC104 
extracts by enzymic methods [167. The metabolite 
changesand 14C02 production between 20 and 60 mm 
were calculated from plots of the values at 20,40 and 
60 min. 
3. Results 
3. I . Effects of y~~pressi~ on ox~da~u~ of (1-‘4C/- 
oleate 
The addition of vasopressin (10 nM) to hepato- 
cytes from fed rats in the presence of Ca2+ (2.4 mM) 
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Table 1 
Comparison of effects of vasopressin, glucagon and dibutyryl cyclic-AMP on 
oxidation of [I-‘?Z]oleate to WO, in hepatocytes from fed rats 
Additions [ 1 -‘“Cl Oleate oxidized to “‘CO, 
None 
Vasopressin (10 nM) 
Glucagon (10 nM) 
Vasopressin (10 nM) + 
glucagon (10 nM) 
Dibutyryl cyclic-AMP (10 PM) 
Vasopressin (10 nM) + 
dibutyryl cyclic-AMP (10 PM) 
ap<0.05; 
b P < 0.0005 
+ CaCl, 
36 * 2 
(29) 
60 f 3 
(26)b 
25 + 2 
(12)b 
38 f 5 
(8) 
31+7 
(3) 
47 + 7 
(3) 
- CaCl, 
33 * 2 
(19) 
40 f 2 
(19)a 
24 + 2 
(1l)a 
28 c 3 
(8) 
23 f 2 
(3)a 
26 k 3 
(3)a 
Production of YO, is expressed as nmol . min“. g wet wt cells-’ and the results 
are mean values ?: SEM with no. obs. in parentheses. Oleate was 1 mM and CaCl, was 
2.4 mM 
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increased oxidation of [ 1 -r4C] oleate to r4C02 by 
66%. The increase was much less in the absence of 
added Ca’+ (table 1). In contrast, glucagon decreased 
[ l-14C]oleate oxidation to r4C02 by 3 1% and a sim- 
ilar decrease was observed in both the presence and 
the absence of Ca*+. Such decreases were also found 
in the presence of dibutyryl cyclic-AMP (table 1). 
When both hormones were present at equimolar con- 
centrations in the presence of Ca*+, the rate of r4C02 
production from [ I- “C]oleate was not significantly 
different from the control value without hormone 
(table 1). In the absence of Ca*+ the rate of oxidation 
of [ 1 -‘4C]oleate in the presence of both vasopressin 
and glucagon or dibutyryl cyclic-AMP was similar to 
that observed in the presence of dibutyryl cyclic-AMP 
alone. 
3.2. Effects of vasopressin on oleate oxidation and 
ketogenesis in the presence of lactate and pyruvate 
The rate of disposal of acetyl-CoA by the tricar- 
boxylic acid cycle may be limited by the availability 
of oxaloacetate for citrate synthesis [ 171. The Km for 
pyruvate of pyruvate carboxylase (0.14 mM) is higher 
than the concentration of pyruvate in the liver 
[ 18,191. Increased availability of lactate and pyruvate 
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should therefore increase the production of oxalo- 
acetate. The decreased rates of ketogenesis from oleate 
observed in the presence of vasopressin are concomi- 
tant with increased rates of lactate [8] and pyruvate 
(unpublished) production. The effects of vasopressin 
on ketogenesis from oleate and on oxidation of 
[ l-14C]oleate to 14C02 in the presence and absence 
of lactate (1 mM) and pyruvate (0.1 mM) were there- 
fore investigated (table 2). Inclusion of lactate and 
pyruvate in the incubation medium increased 14C02 
production from [ l-14C]oleate. Vasopressin increased 
oxidation in both the presence and absence of lactate 
and pyruvate (table 2). Maximal effects were observed 
in the presence of lactate and pyruvate and vaso- 
pressin (table 2). In both the presence of lactate and 
pyruvate, and the presence of vasopressin, the increases 
in 14C02 production were associated with decreased 
ketone body production. Again, maximal effects were 
observed when all three were present (table 2). 
3.3. Calcium dependency of the antiketogenic effect 
of vasopressin 
Vasopressin depressed ketone body formation 
from oleate in the presence of Ca*+ (table 3). This 
effect of vasopressin was decreased in the absence of 
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Table 2 
Effects of lactate and pyruvate on [ 1 -Y]oleate oxidation in hepatocytes from fed rats 
Additions [ I-r4C]oleate oxidized to r4C0, Ketone body production 
None 
Lactate (1 mM) + 
pyruvate (0.1 mM) 
Vasopressin (10 nM) 
Lactate (1 mM) + 
pyruvate (0.1 mM) + 
vasopressin (10 nM) 
a P < 0.05; 
b P < 0.005; 
c P < 0.0005 
+ CaCl, 
31+3 
(8) 
38 t 4 
(8) 
54 + 5 
(8)’ 
66 f 7 
(6)’ 
- CaCl, 
30 + 3 
(6) 
36 f 2 
(6) 
39 -t 4 
Wa 
48 f 4 
(4)b 
+ CaCI, 
713?55 
(12) 
575233 
(12)a 
463 f 50 
(12)b 
332 f 35 
(LO)C 
- CaCI, 
545 ?: 58 
(6) 
421 f 52 
(6) 
458 f 50 
(6) 
349 + 80 
(4)a 
Production of “‘CO, is expressed as nmol . min . g wt cells-’ and the results are mean values k SEM 
with no. obs. in parentheses. Oleate was 1 mM and CaCl, was 2.4 mM 
Ca*+ (table 3). In marked contrast, esterification of 
[ 1 -14C]oleate was stimulated by vasopressin both in 
the presence and absence of calcium (table 2). This 
implies that the decreased rate of ketogenesis observed 
in the presence of vasopressin is not a consequence 
of an increased rate of esteritication. However, in the 
same experiments increased oxidation of [ 1 -r4C] - 
oleate in response to vasopressin was Ca*+dependent 
(table 3, see also table 1). Thus decreased ketogenesis 
from oleate may be related to increased oxidation of 
oleate .
4. Discussion 
Vasopressin increases conversion of oleate into 
esterified products in hepatocytes from fed rats [8]. 
These studies demonstrate that, in addition to this 
extramitochondrial effect of vasopressin, the hormone 
has an intramitochondrial site of action, namely 
increased r4C02 production from [ 1 -14C] oleate. 
Increased oxidation in response to vasopressin is 
observed in both the absence and in the presence of 
lactate and pyruvate. The increase in r4C02 produc- 
Table 3 
Effects of vasopressin on esterification and oxidation of [ l-‘4C]oleate and on ketogenesis in the presence or absence of Caz+ 
None 
Vasopressin 
(10 nM) 
a P < 0.01; 
b P < 0.0005 
[ I-r4C]Oleate esterified 
+ CaCl, - CaCl, 
187 ? 16 203 f 25 
(9) (9) 
304 f 27 322 f 42 
(9)b (9)a 
[ I-%]Oleate oxidized to 14C0, 
+ CaCl, - CaCl, 
36 +5 34 j: 4 
(9) (9) 
61 *7 39 f 4 
(8)a (9) 
Ketone body production 
+ CaCl, - CaCI, 
662 f 31 664 ? 40 
(26) (21) 
413 f 40 580 f 42 
(27)b (19) 
Metabolic rates expressed as nmol . min-’ . g wet wt cell-’ and the results are mean values + SEM with no. obs. in parentheses. 
Oleate was 1 mM and CaCl, was 2.4 mM. 
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tion observed in the presence of lactate and pyruvate 
is presumably due to increased oxaloacetate availabil- 
ity. The additional change in 14C02 production pro- 
duced by vasopressin i  the presence of lactate and 
pyruvate is therefore likely to be due to a different 
mecha~sm. A possible action of vasopressin to
decrease ntry of long-chain acyl-CoA into the mito- 
chondria might account for part of the antiketogenic 
effect. If such an action were secondary to a change 
in malonyl-CoA concentration, it could not account 
for the decreased ketogenesis elicited by vasopressin 
in the presence of lactate and pyruvate. Under these 
conditons the rate of lipogenesis (and presumably 
the malonyl-CoA concentration) was not further 
increased by vasopressin (control (3) 0.072 + 0.006 
pmol 3Hz0. mm-’ . g fresh wt cells-‘; plus vasopressin 
(3) 0.075 + 0.004 /..unol 3Hz0 . mitt-‘. g wet wt 
cells-r). Moreover, 52% of the decrease in ketone 
body production observed on addition of vasopressin 
in the presence of lactate and pyruvate can be attri- 
buted to increased complete oxidation of oleate 
(table 2). 
Both the increased oxidation to 14C02 of [ f -r4C] - 
oleate in response to vasopre~~, and the antiketog- 
enic action of vasopressin were dependent on the 
addition of Ca2+ to the incubation medium. In con- 
trast, esterification was stimulated by vasopressin 
both in the presence and absence of Ca”‘. This obser- 
vation suggests hat the ~tr~ito~ond~~ site of 
action of vasopressin plays the major role in the anti- 
ketogenic effect of the hormone when oleate is the 
exogenous substrate. Indeed, assuming the complete 
oxidation of oleoyl-CoA to acetyl-CoA, the data given 
in table 3 indicate that 45% of the decrease in ketone 
body production elicited by vasopressin can be 
accounted for by increased oxidation of oleate, The 
mechanism by which vasopressin creases 14C02 pro- 
duction from [ I- i4C] oleate is not known. Such an 
increase might result from increased tricarboxylic 
acid cycle turnover. As it has been reported that cer- 
tain enzymes of the t~carboxy~c acid cycle are acti- 
vated by Ca” [20,21] and vasopressin does not 
increase 14C02 production in the absence of Ca”‘, it 
is possible that the hormone exerts its effects by an 
increase in the mitochondrial Ca2* concentration. 
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